BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6159910)

  • 21. Beta 2 microglobulin in multiple myeloma.
    Alexanian R; Barlogie B; Fritsche H
    Am J Hematol; 1985 Dec; 20(4):345-51. PubMed ID: 3907332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels.
    Scudla V; Budíková M; Fischerová E; Zadrazil J; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():201-12. PubMed ID: 1838869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
    Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
    Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta 2-microglobulin in monoclonal gammopathies.
    Vercelli D; Cozzolino F; Becucci A; Di Guglielmo R
    Nouv Rev Fr Hematol (1978); 1982; 24(2):85-8. PubMed ID: 6180380
    [No Abstract]   [Full Text] [Related]  

  • 25. [Is the serum level of beta 2 microglobulin a better marker of glomerular filtration than blood creatinine?].
    François B; Assenat H; Cahen R; Bizollon C
    Nephrologie; 1982; 3(3):116-8. PubMed ID: 6183598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta 2-microglobulin: a potentially useful marker for hematologic malignancies.
    Garewal H; Durie BG
    Ariz Med; 1981 Dec; 38(12):912-3. PubMed ID: 6174109
    [No Abstract]   [Full Text] [Related]  

  • 27. [Beta 2 microglobulin].
    Clément F
    Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Carcino-embryonic antigen and beta 2 microglobulin in malignant bone diseases. 61 cases (author's transl)].
    Trèves R; Clément A; Desproges-Gotteron R; Olivier JP; Beck C
    Nouv Presse Med; 1982 Jan; 11(1):21-4. PubMed ID: 6173840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of serum beta-2 microglobulin levels in breast cancer patients.
    Papaioannou D; Geggie P; Klassen J
    Clin Chim Acta; 1979 Nov; 99(1):37-41. PubMed ID: 91458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum beta 2-microglobulin in myelomatosis.
    Child JA; Norfolk DR; Cooper EH
    Br J Haematol; 1986 Jun; 63(2):406-7. PubMed ID: 3521716
    [No Abstract]   [Full Text] [Related]  

  • 31. Beta 2-microglobulin in haematological malignancies.
    Br Med J (Clin Res Ed); 1981 Mar; 282(6269):1013. PubMed ID: 6163499
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prognostic importance of beta-2-microglobulin in multiple myeloma].
    Avilés A; Zepeda G; Guzmán R; Talavera A; García EL; Díaz-Maqueo JC
    Rev Invest Clin; 1992; 44(2):215-20. PubMed ID: 1439309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum beta 2-microglobulin, serum creatinine and bone marrow plasma cells in benign and malignant monoclonal gammopathy.
    Morell A; Riesen W
    Acta Haematol; 1980; 64(2):87-93. PubMed ID: 6159767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum beta-2-microglobulin in multiple myeloma: relation to presenting features and clinical status.
    Bataille R; Magub M; Grenier J; Donnadio D; Sany J
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):59-66. PubMed ID: 6177535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of the assay of serum beta 2 microglobulin in the clinical evaluation of myeloma].
    Bataille R; Grenier J
    Presse Med; 1986 Oct; 15(34):1723-5. PubMed ID: 2947132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum beta 2-microglobulin in multiple myeloma. I. Relation to selected indicators, clinical stage and disease prognosis].
    Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V
    Vnitr Lek; 1991 Apr; 37(4):342-51. PubMed ID: 2053304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and application of beta-2-microglobulin measurements to detect acute transplant rejection.
    Roxe DM; Siddiqui F; Santhanam S; del Greco F; Wolf J
    Nephron; 1981; 27(4-5):260-4. PubMed ID: 6167873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy-specific beta 1-glycoprotein in serum in monoclonal gammopathies: relationship with serum beta 2-microglobulin, and cellular origin.
    Fagnart OC; Tasiaux N; Masson PL
    Clin Chem; 1986 Dec; 32(12):2150-4. PubMed ID: 3096609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum beta2-microglobulin in the assessment of renal function.
    Bailey RR; Tisch GW; Pearson S
    N Z Med J; 1978 Mar; 87(607):168-70. PubMed ID: 77514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary pseudouridine excretion in myelomatosis.
    Sørensen SH; Brown DA; Cooper EH; Kelly KA; MacLennan IC
    Br J Cancer; 1985 Dec; 52(6):863-6. PubMed ID: 3907686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.